Understanding and Overcoming the Early Adaptive Resistance to EGFR Tyrosine-kinase Inhibitors in Lung Cancer Patients

NCT04222335 · clinicaltrials.gov ↗
NA
Phase
ACTIVE_NOT_RECRUITING
Status
80
Enrollment
OTHER
Sponsor class

Conditions

Interventions

Sponsor

University Hospital, Toulouse

Collaborators